| Proton-sensing G-protein-coupled receptors MG Ludwig, M Vanek, D Guerini, JA Gasser, CE Jones, U Junker, ... Nature 425 (6953), 93-98, 2003 | 750 | 2003 |
| TNF-induced structural joint damage is mediated by IL-1 J Zwerina, K Redlich, K Polzer, L Joosten, G Krönke, J Distler, A Hess, ... Proceedings of the National Academy of Sciences 104 (28), 11742-11747, 2007 | 395 | 2007 |
| Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH (1–34)] in postmenopausal osteoporosis F Cosman, EF Eriksen, C Recknor, PD Miller, N Guañabens, C Kasperk, ... Journal of Bone and Mineral Research 26 (3), 503-511, 2011 | 390 | 2011 |
| Effects of intravenous zoledronic acid once yearly on bone remodeling and bone structure RR Recker, PD Delmas, J Halse, IR Reid, S Boonen, ... Journal of Bone and Mineral Research 23 (1), 6-16, 2008 | 293 | 2008 |
| Antitumor effects of clinical dosing regimens of bisphosphonates in experimental breast cancer bone metastasis F Daubiné, C Le Gall, J Gasser, J Green, P Clézardin Journal of the National Cancer Institute 99 (4), 322-330, 2007 | 282 | 2007 |
| Monitoring individual morphological changes over time in ovariectomized rats by in vivo micro-computed tomography SK Boyd, P Davison, R Müller, JA Gasser Bone 39 (4), 854-862, 2006 | 266 | 2006 |
| A cathepsin K inhibitor reduces breast cancer–induced osteolysis and skeletal tumor burden C Le Gall, A Bellahcene, E Bonnelye, JA Gasser, V Castronovo, J Green, ... Cancer research 67 (20), 9894-9902, 2007 | 235 | 2007 |
| The molecular scaffold Gab2 is a crucial component of RANK signaling and osteoclastogenesis T Wada, T Nakashima, AJ Oliveira-dos-Santos, J Gasser, H Hara, ... Nature medicine 11 (4), 394-399, 2005 | 215 | 2005 |
| The effect on vertebral bone mass and strength of long term treatment with antiresorptive agents (estrogen and calcitonin), human parathyroid hormone-(1-38), and combination … L Mosekilde, CC Danielsen, J Gasser Endocrinology 134 (5), 2126-2134, 1994 | 181 | 1994 |
| Interleukin-1 is essential for systemic inflammatory bone loss K Polzer, L Joosten, J Gasser, JH Distler, G Ruiz, W Baum, K Redlich, ... Annals of the rheumatic diseases 69 (01), 284-290, 2010 | 164 | 2010 |
| Zoledronic acid protects against local and systemic bone loss in tumor necrosis factor–mediated arthritis P Herrak, B Görtz, S Hayer, K Redlich, E Reiter, J Gasser, H Bergmeister, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2004 | 142 | 2004 |
| Bone tissue and its mineralization in aged estrogen-depleted rats after long-term intermittent treatment with parathyroid hormone (PTH) analog SDZ PTS 893 or human PTH (1-34) M Kneissel, A Boyde, JA Gasser Bone 28 (3), 237-250, 2001 | 139 | 2001 |
| Long‐term protective effects of zoledronic acid on cancellous and cortical bone in the ovariectomized rat JA Gasser, P Ingold, A Venturiere, V Shen, JR Green Journal of bone and mineral research 23 (4), 544-551, 2008 | 138 | 2008 |
| Circulating fibronectin affects bone matrix, whereas osteoblast fibronectin modulates osteoblast function A Bentmann, N Kawelke, D Moss, H Zentgraf, Y Bala, I Berger, JA Gasser, ... Journal of Bone and Mineral Research 25 (4), 706-715, 2010 | 125 | 2010 |
| Multi-lineage potential of human mesenchymal stem cells following clonal expansion C Halleux, V Sottile, JA Gasser, K Seuwen Journal of Musculoskeletal and Neuronal Interactions 2 (1), 71-76, 2001 | 124 | 2001 |
| Bone material properties in actively bone‐forming trabeculae in postmenopausal women with osteoporosis after three years of treatment with once‐yearly zoledronic acid S Gamsjaeger, B Buchinger, E Zwettler, R Recker, D Black, JA Gasser, ... Journal of Bone and Mineral Research 26 (1), 12-18, 2011 | 116 | 2011 |
| Bone degeneration and recovery after early and late bisphosphonate treatment of ovariectomized wistar rats assessed by in vivo micro-computed tomography JEM Brouwers, FM Lambers, JA Gasser, B Van Rietbergen, R Huiskes Calcified tissue international 82, 202-211, 2008 | 105 | 2008 |
| Evaluation of Three-dimensional Image Registration Methodologies for In Vivo Micro-computed Tomography SK Boyd, S Moser, M Kuhn, RJ Klinck, PL Krauze, R Müller, JA Gasser Annals of biomedical engineering 34, 1587-1599, 2006 | 88 | 2006 |
| Dlk1/FA1 is a novel endocrine regulator of bone and fat mass and its serum level is modulated by growth hormone BM Abdallah, M Ding, CH Jensen, N Ditzel, A Flyvbjerg, TG Jensen, ... Endocrinology 148 (7), 3111-3121, 2007 | 78 | 2007 |
| Models of tibial fracture healing in normal and Nf1‐deficient mice A Schindeler, A Morse, L Harry, C Godfrey, K Mikulec, M McDonald, ... Journal of orthopaedic research 26 (8), 1053-1060, 2008 | 74 | 2008 |
